glp-1 market news New news: a major ad-trust fight just hit the weight loss drug space. The Guardian reports Ozempic maker Novo Nordisk is suing a US rival over what it calls “materially GLP-1 Receptor Agonist Market Growth

If youve been struggling with weight despite dedicated efforts with diet and exercise, youre not alone

NATURAL COURSE OF GD AND CLINICAL MANIFESTATIONS OF THYROTOXICOSIS In the classic presentation, the most common onset is the simultaneous and gradual development, over a period of weeks or months, of thyrotoxicosis-related signs and symptoms, goiter, and exophthalmos

Stronger Physical and Mental Health At the heart of physical and mental vitality lies vitamin B12

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology

Front Neurol

Thus, ALA and DHLA act as antioxidants not only directly, through metal chelation and free radical quenching, but also indirectly, both through the recycling of other antioxidants and by inducing an increase in intracellular GSH levels